Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Urinary Antigen Test Kit Evaluated for Diagnosing Legionella Pneumonia

By LabMedica International staff writers
Posted on 24 Feb 2021
Legionellosis is caused by bacteria called Legionella. More...
The disease has two different forms. Legionnaires’ disease is the more severe form of infection that causes pneumonia. Pontiac fever is caused by the same bacteria, but is a milder illness without pneumonia.

Various examinations are performed for the diagnosis of Legionella pneumonia, including urinary antigen tests, respiratory specimen cultures, nucleic acid detection tests, and serum antibody tests. Although culture of Legionella species from a respiratory specimen is the diagnostic gold standard, it is time consuming. L. pneumophila is divided into 15 serogroups (SG).

A large team of medical microbiologists and their colleagues at Kurashiki Central Hospital (Kurashiki, Japan) enrolled prospectively pneumonia patients suspected by attending physicians to have disease caused by Legionella species based on symptoms, laboratory examinations, and radiological findings, and whose urine samples could be collected, from 16 hospitals in Japan from April 2016 to December 2018.

Three urinary antigen test kits were used: the novel kit (LAC-116 Asahi Kasei Pharma Corporation, Tokyo, Japan), BinaxNOW Legionella (Binax, Abbott Park, IL, USA), and Q-line Kyokutou Legionella (Q-line, Kyokutou Corporation, Tokyo, Japan). In addition, sputum culture and nucleic acid detection tests and serum antibody tests were performed where possible. The diagnostic accuracy and correlations of the novel kit with the two existing kits were analyzed.

The scientists reported that in total, 56 patients were diagnosed with Legionella pneumonia. The sensitivities of LAC-116, Binax, and Q-line were 79%, 84%, and 71%, respectively. The overall match rate between LAC-116 and Binax was 96.8% and between LAC-116 and Q-line was 96.4%. One patient had L. pneumophila serogroup 2, and only LAC-116 showed a positive result, whereas Binax and Q-line did not.

The authors concluded that the novel kit can theoretically diagnose Legionella pneumonia due to both L. pneumophila SG1 and non-SG1, and it is therefore useful for diagnosing Legionella pneumonia. In the future, early and appropriate diagnosis of Legionella pneumonia due to non-L. pneumophila SG1 can be expected with this novel kit. The team believes that the use of this kit may improve the prognosis of Legionella pneumonia patients. The study was published on February 1, 2021 in the International Journal of Infectious Diseases.

Related Links:
Kurashiki Central Hospital
Asahi Kasei Pharma Corporation
Binax
Kyokutou Corporation



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.